New gel for infected wounds enters first human test
Disease control
Recruiting now
This early-stage trial tests a new gel called Amicidin-β, applied directly into infected surgical or traumatic wounds during a procedure. The main goal is to see if it is safe and easy for surgeons to use. About 44 adults will take part, comparing standard care alone to standard …
Phase: PHASE1 • Sponsor: Macro Biologics, Inc. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC